Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

End-of-life experiences in dementia with Lewy bodies: Qualitative interviews with former caregivers.

Armstrong MJ, Alliance S, Taylor A, Corsentino P, Galvin JE.

PLoS One. 2019 May 30;14(5):e0217039. doi: 10.1371/journal.pone.0217039. eCollection 2019.

2.

Reliability and Validity of SymTrak, a Multi-Domain Tool for Monitoring Symptoms of Older Adults with Multiple Chronic Conditions.

Monahan PO, Kroenke K, Callahan CM, Bakas T, Harrawood A, Lofton P, Frye D, Draucker C, Stump T, Saliba D, Galvin JE, Keegan A, Austrom MG, Boustani M.

J Gen Intern Med. 2019 Jun;34(6):908-914. doi: 10.1007/s11606-018-4780-4. Epub 2019 Apr 18.

PMID:
31001721
3.

Development and Feasibility of SymTrak, aMulti-domain Tool for Monitoring Symptoms of Older Adults in Primary Care.

Monahan PO, Kroenke K, Callahan CM, Bakas T, Harrawood A, Lofton P, Frye D, Draucker C, Stump T, Saliba D, Galvin JE, Keegan A, Austrom MG, Boustani M.

J Gen Intern Med. 2019 Jun;34(6):915-922. doi: 10.1007/s11606-018-4772-4. Epub 2019 Mar 25.

PMID:
30912032
4.

Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings.

Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, Domoto-Reilly K, Duda J, Gomperts S, Graff-Radford N, Holden S, Honig L, Huddleston D, Lippa C, Litvan I, Manning C, Marder K, Moussa C, Onyike C, Pagan F, Pantelyat A, Pelak V, Poston K, Quinn J, Richard I, Rosenthal LS, Sabbagh M, Scharre D, Sha S, Shill H, Torres-Yaghi Y, Christie T, Graham T, Richards I, Koehler M, Boeve B.

Alzheimers Res Ther. 2019 Mar 13;11(1):23. doi: 10.1186/s13195-019-0476-1.

5.

Alzheimer's "Prevention" vs. "Risk Reduction": Transcending Semantics for Clinical Practice.

Hodes JF, Oakley CI, O'Keefe JH, Lu P, Galvin JE, Saif N, Bellara S, Rahman A, Kaufman Y, Hristov H, Rajji TK, Fosnacht Morgan AM, Patel S, Merrill DA, Kaiser S, Meléndez-Cabrero J, Melendez JA, Krikorian R, Isaacson RS.

Front Neurol. 2019 Jan 21;9:1179. doi: 10.3389/fneur.2018.01179. eCollection 2018.

6.

Rural stakeholder perceptions about cognitive screening.

Kirk Wiese L, Galvin JE, Williams CL.

Aging Ment Health. 2018 Dec 27:1-13. doi: 10.1080/13607863.2018.1525607. [Epub ahead of print]

PMID:
30588841
7.

Perceived burden among caregivers of patients with frontotemporal degeneration in the United States.

Besser LM, Galvin JE.

Int Psychogeriatr. 2018 Nov 6:1-11. doi: 10.1017/S104161021800159X. [Epub ahead of print]

PMID:
30398132
8.

Reducing disability via a family centered intervention for acutely ill persons with Alzheimer's disease and related dementias: protocol of a cluster-randomized controlled trial (Fam-FFC study).

Boltz M, Kuzmik A, Resnick B, Trotta R, Mogle J, BeLue R, Leslie D, Galvin JE.

Trials. 2018 Sep 17;19(1):496. doi: 10.1186/s13063-018-2875-1.

9.

Using Informant and Performance Screening Methods to Detect Mild Cognitive Impairment and Dementia.

Galvin JE.

Curr Geriatr Rep. 2018 Mar;7(1):19-25. doi: 10.1007/s13670-018-0236-2. Epub 2018 Jan 26.

10.

Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.

Goldman JG, Vernaleo BA, Camicioli R, Dahodwala N, Dobkin RD, Ellis T, Galvin JE, Marras C, Edwards J, Fields J, Golden R, Karlawish J, Levin B, Shulman L, Smith G, Tangney C, Thomas CA, Tröster AI, Uc EY, Coyan N, Ellman C, Ellman M, Hoffman C, Hoffman S, Simmonds D.

NPJ Parkinsons Dis. 2018 Jun 26;4:19. doi: 10.1038/s41531-018-0055-3. eCollection 2018. Review.

11.

Sarcopenic obesity and cognitive performance.

Tolea MI, Chrisphonte S, Galvin JE.

Clin Interv Aging. 2018 Jun 6;13:1111-1119. doi: 10.2147/CIA.S164113. eCollection 2018.

12.

The genetics of dementia with Lewy bodies.

Tolea MI, Galvin JE.

Handb Clin Neurol. 2018;148:431-440. doi: 10.1016/B978-0-444-64076-5.00028-4. Review.

PMID:
29478592
13.

The social and economic burden of frontotemporal degeneration.

Galvin JE, Howard DH, Denny SS, Dickinson S, Tatton N.

Neurology. 2017 Nov 14;89(20):2049-2056. doi: 10.1212/WNL.0000000000004614. Epub 2017 Oct 4.

14.

Use of the Quick Dementia Rating System (QDRS) as an Initial Screening Measure in a Longitudinal Cohort at Risk for Alzheimer's Disease.

Berman SE, Koscik RL, Clark LR, Mueller KD, Bluder L, Galvin JE, Johnson SC.

J Alzheimers Dis Rep. 2017;1(1):9-13. doi: 10.3233/ADR-170004. Epub 2017 Apr 28.

15.

Prevention of Alzheimer's Disease: Lessons Learned and Applied.

Galvin JE.

J Am Geriatr Soc. 2017 Oct;65(10):2128-2133. doi: 10.1111/jgs.14997. Epub 2017 Aug 2.

16.

Improving data collection, documentation, and workflow in a dementia screening study.

Read KB, LaPolla FW, Tolea MI, Galvin JE, Surkis A.

J Med Libr Assoc. 2017 Apr;105(2):160-166. doi: 10.5195/jmla.2017.221.

17.

Validation of the Korean Version of the Lewy Body Composite Risk Score (K-LBCRS).

Ryu HJ, Kim M, Moon Y, Choi Y, Han JY, Galvin JE, Han SH.

J Alzheimers Dis. 2017;55(4):1395-1401. doi: 10.3233/JAD-160463.

PMID:
27834773
18.

Arguing against the proposed definition changes of PD.

Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, Singleton AB, Taylor A, Tsuang D, Weintraub D, Zabetian CP.

Mov Disord. 2016 Nov;31(11):1619-1622. doi: 10.1002/mds.26721. Epub 2016 Aug 5.

19.
20.

The Relationship Between Mobility Dysfunction Staging and Global Cognitive Performance.

Tolea MI, Galvin JE.

Alzheimer Dis Assoc Disord. 2016 Jul-Sep;30(3):230-6. doi: 10.1097/WAD.0000000000000136.

21.

Anosognosia increases caregiver burden in mild cognitive impairment.

Kelleher M, Tolea MI, Galvin JE.

Int J Geriatr Psychiatry. 2016 Jul;31(7):799-808. doi: 10.1002/gps.4394. Epub 2015 Dec 7.

PMID:
26643996
22.
23.

THE QUICK DEMENTIA RATING SYSTEM (QDRS): A RAPID DEMENTIA STAGING TOOL.

Galvin JE.

Alzheimers Dement (Amst). 2015 Jun 1;1(2):249-259.

24.

Testing family-centered, function-focused care in hospitalized persons with dementia.

Boltz M, Chippendale T, Resnick B, Galvin JE.

Neurodegener Dis Manag. 2015;5(3):203-15. doi: 10.2217/nmt.15.10.

25.

Trajectory of Mobility Decline by Type of Dementia.

Tolea MI, Morris JC, Galvin JE.

Alzheimer Dis Assoc Disord. 2016 Jan-Mar;30(1):60-6. doi: 10.1097/WAD.0000000000000091.

26.

Sarcopenia and impairment in cognitive and physical performance.

Tolea MI, Galvin JE.

Clin Interv Aging. 2015 Mar 30;10:663-71. doi: 10.2147/CIA.S76275. eCollection 2015.

27.

Longitudinal associations between physical and cognitive performance among community-dwelling older adults.

Tolea MI, Morris JC, Galvin JE.

PLoS One. 2015 Apr 13;10(4):e0122878. doi: 10.1371/journal.pone.0122878. eCollection 2015.

28.

Comment: Too much of a good thing may still be good for your brain.

Galvin JE.

Neurology. 2015 May 5;84(18):1859. doi: 10.1212/WNL.0000000000001547. Epub 2015 Apr 8. No abstract available.

PMID:
25854870
29.

Onset of Mild Cognitive Impairment in Parkinson Disease.

Johnson DK, Langford Z, Garnier-Villarreal M, Morris JC, Galvin JE.

Alzheimer Dis Assoc Disord. 2016 Apr-Jun;30(2):127-33. doi: 10.1097/WAD.0000000000000088.

30.

Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch.

Molinuevo JL, Frölich L, Grossberg GT, Galvin JE, Cummings JL, Krahnke T, Strohmaier C.

Alzheimers Res Ther. 2015 Mar 8;7(1):9. doi: 10.1186/s13195-014-0088-8. eCollection 2015.

31.

Skin reactions at the application site of rivastigmine patch (4.6 mg/24 h, 9.5 mg/24 h or 13.3 mg/24 h): a qualitative analysis of clinical studies in patients with Alzheimer's disease.

Alva G, Cummings JL, Galvin JE, Meng X, Velting DM.

Int J Clin Pract. 2015 May;69(5):518-30. doi: 10.1111/ijcp.12621. Epub 2015 Feb 16.

PMID:
25684069
32.

Anxiety in family caregivers of hospitalized persons with dementia: contributing factors and responses.

Boltz M, Chippendale T, Resnick B, Galvin JE.

Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):236-41. doi: 10.1097/WAD.0000000000000072.

33.

Collaborative transdisciplinary team approach for dementia care.

Galvin JE, Valois L, Zweig Y.

Neurodegener Dis Manag. 2014;4(6):455-69. doi: 10.2217/nmt.14.47. Review.

34.

Pathological correlates of white matter hyperintensities on magnetic resonance imaging.

Shim YS, Yang DW, Roe CM, Coats MA, Benzinger TL, Xiong C, Galvin JE, Cairns NJ, Morris JC.

Dement Geriatr Cogn Disord. 2015;39(1-2):92-104. doi: 10.1159/000366411. Epub 2014 Nov 8.

35.

Cortical-subcortical interactions in hypersomnia disorders: mechanisms underlying cognitive and behavioral aspects of the sleep-wake cycle.

Larson-Prior LJ, Ju YE, Galvin JE.

Front Neurol. 2014 Sep 11;5:165. doi: 10.3389/fneur.2014.00165. eCollection 2014. Review.

36.

Current guidelines for dementia screening: shortcomings and recommended changes.

Tolea MI, Galvin JE.

Neurodegener Dis Manag. 2013 Dec;3(6):565-573.

37.

Lewy body dementia: the impact on patients and caregivers.

Zweig YR, Galvin JE.

Alzheimers Res Ther. 2014 Apr 25;6(2):21. doi: 10.1186/alzrt251. eCollection 2014. Review.

38.

Vocalization in dementia: a case report and review of the literature.

Yusupov A, Galvin JE.

Case Rep Neurol. 2014 Apr 30;6(1):126-33. doi: 10.1159/000362159. eCollection 2014 Jan.

39.

Lewy Body Dementia: The Under-Recognized but Common FOE.

Galvin JE, Balasubramaniam M.

Cerebrum. 2013 Oct 1;2013:13. eCollection 2013 Sep.

40.

Efficacy of a flexible schedule for administration of a Leptospira borgpetersenii serovar Hardjo bacterin to beef calves.

Cortese VS, Gallo GF, Cleary DL, Galvin JE, Leyh RD.

Am J Vet Res. 2014 May;75(5):507-12. doi: 10.2460/ajvr.75.5.507.

PMID:
24762025
41.

The spectrum of cognitive impairment in Lewy body diseases.

Goldman JG, Williams-Gray C, Barker RA, Duda JE, Galvin JE.

Mov Disord. 2014 Apr 15;29(5):608-21. doi: 10.1002/mds.25866. Review.

42.

Public-private partnerships improve health outcomes in individuals with early stage Alzheimer's disease.

Galvin JE, Tolea MI, George N, Wingbermuehle C.

Clin Interv Aging. 2014 Apr 10;9:621-30. doi: 10.2147/CIA.S60838. eCollection 2014.

43.

Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer's disease.

Micca JL, Galvin JE, Velting DM, Meng X.

SAGE Open Med. 2014 Dec 1;2:2050312114561569. doi: 10.1177/2050312114561569. eCollection 2014.

44.

Identification of streptococcal m-protein cardiopathogenic epitopes in experimental autoimmune valvulitis.

Kirvan CA, Galvin JE, Hilt S, Kosanke S, Cunningham MW.

J Cardiovasc Transl Res. 2014 Mar;7(2):172-81. doi: 10.1007/s12265-013-9526-4. Epub 2013 Dec 18.

45.

Facilitating Alzheimer disease research recruitment.

Grill JD, Galvin JE.

Alzheimer Dis Assoc Disord. 2014 Jan-Mar;28(1):1-8. doi: 10.1097/WAD.0000000000000016. Review.

46.

Comparison of 2 informant questionnaire screening tools for dementia and mild cognitive impairment: AD8 and IQCODE.

Razavi M, Tolea MI, Margrett J, Martin P, Oakland A, Tscholl DW, Ghods S, Mina M, Galvin JE.

Alzheimer Dis Assoc Disord. 2014 Apr-Jun;28(2):156-61. doi: 10.1097/WAD.0000000000000008.

47.

Whipple's disease masquerades as dementia with Lewy bodies.

Hurth K, Tarawneh R, Ghoshal N, Benzinger TLS, Clifford DB, Geschwind M, Morris JC, Galvin JE, Schmidt RE, Cairns NJ.

Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):85-89. doi: 10.1097/WAD.0b013e3182a715da. No abstract available.

48.

UPDATE ON DEMENTIA WITH LEWY BODIES.

Karantzoulis S, Galvin JE.

Curr Transl Geriatr Exp Gerontol Rep. 2013 Sep 1;2(3):196-204.

49.

A review of interprofessional dissemination and education interventions for recognizing and managing dementia.

Brody AA, Galvin JE.

Gerontol Geriatr Educ. 2013;34(3):225-56. doi: 10.1080/02701960.2013.801342. Review.

50.

Implementation of geriatric acute care best practices: initial results of the NICHE SITE self-evaluation.

Boltz M, Capezuti E, Shuluk J, Brouwer J, Carolan D, Conway S, DeRosa S, LaReau R, Lyons D, Nickoley S, Smith T, Galvin JE.

Nurs Health Sci. 2013 Dec;15(4):518-24. doi: 10.1111/nhs.12067. Epub 2013 May 9.

Supplemental Content

Loading ...
Support Center